Acetylsalicylic acid and Optiray 350 drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Acetylsalicylic acid (aspirin) and Optiray 350 (ioversol). Common drug interactions include anxiety among females and anxiety among males.

The phase IV clinical study analyzes what interactions people have when they take Acetylsalicylic acid and Optiray 350. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Acetylsalicylic acid?

Acetylsalicylic acid has active ingredients of aspirin. It is often used in high blood pressure. eHealthMe is studying from 119,766 Acetylsalicylic acid users. Check the latest studies of Acetylsalicylic acid.

What is Optiray 350?

Optiray 350 has active ingredients of ioversol. eHealthMe is studying from 1,523 Optiray 350 users. Check the latest studies of Optiray 350.



On Jul, 14, 2026

20 people who take Acetylsalicylic acid and Optiray 350 together, and have interactions are studied.

Acetylsalicylic acid and Optiray 350 drug interactions.

What are the common drug interactions of Acetylsalicylic Acid and Optiray 350, by gender? *:

female:

  1. Anxiety
  2. Injury
  3. Renal failure (kidney dysfunction)
  4. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  5. Emotional distress
  6. Fear
  7. Pain
  8. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  9. Depression
  10. Death

male:

  1. Anxiety
  2. Fear
  3. Multi-organ failure (multisystem organ failure)
  4. Death
  5. Depression
  6. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  7. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  8. Insomnia (sleeplessness)
  9. Pain
  10. Renal failure (kidney dysfunction)

What are the common drug interactions of Acetylsalicylic Acid and Optiray 350, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Anxiety
  2. Depression
  3. Emotional distress
  4. Fear
  5. Injury
  6. Pain
  7. Renal failure (kidney dysfunction)
  8. Adverse event
  9. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  10. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)

60+:

  1. Anxiety
  2. Renal failure (kidney dysfunction)
  3. Multi-organ failure (multisystem organ failure)
  4. Death
  5. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  6. Depression
  7. Nervousness
  8. Sepsis (a severe blood infection that can lead to organ failure and death)
  9. Fear
  10. Pain

What are the existing conditions these people have? *

  1. High Blood Cholesterol: 3 people, 15.00%
  2. Nuclear Magnetic Resonance Imaging Brain: 2 people, 10.00%
  3. Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 2 people, 10.00%
  4. Muscle Function Loss: 2 people, 10.00%
  5. Inflammation: 2 people, 10.00%
  6. Coronary Revascularisation: 2 people, 10.00%
  7. Coronary Heart Disease (narrowing or blockage of the coronary arteries): 2 people, 10.00%
  8. Cardiac Output Increased: 2 people, 10.00%
  9. Bleeding Disorders: 2 people, 10.00%
  10. Arrhythmias (irregular heartbeat): 2 people, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Acetylsalicylic acid and Optiray 350?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Acetylsalicylic acid and Optiray 350:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Acetylsalicylic acid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Optiray 350:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Acetylsalicylic acid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Optiray 350 and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on aspirin and ioversol (the active ingredients of Acetylsalicylic acid and Optiray 350, respectively), and Acetylsalicylic acid and Optiray 350 (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: